The Center for Cancer and Blood Disorders proudly announces that Dr. Parra has been honored as one of the Top 150 Physicians in the Nation for Prostate Cancer! This recognition highlights his dedication, expertise, and the compassionate care he provides to every patient....
News
The Center Brings You Patient Care Enhancements
I-131 Thyroid Cancer Treatment
Congratulations to Dr. Weng, the entire radiation oncology department, and our Las Colinas office for successfully treating their first thyroid cancer patient with I-131 radioactive iodine! Dr. Weng and the radiation oncology team built the program from the ground up. It allows us to provide an important treatment option for our patients after resection of...
Bille Burton and BITE Therapy
Our medical oncology team in Ft Worth was the first in Tarrant County to treat a patient with BITE therapy for aggressive lymphoma- representing one of the newest treatment options for patients with advanced lymphoma. https://youtu.be/ejcxJ1d_pPg
Jodi McCartney Discusses Breast Cancer Awareness
Dr. Gallaty Talks About The Different Options for Breast Cancer Surgery
Dr. Page Mentoring Young Doctors Desiring to Become Oncologists
Several years ago HCA Weatherford established a new Internal Medicine Residency Program. Dr. Ray Page played an integral part in the development of the program and served on the founding Graduate Medical Education Committee, participating in didactic education, directing tumor boards, and supervising the clinical rotations in hematology and oncology. The...
Dr. Weng discusses the True Beam at our Arlington Clinic
Dr. Page Presents at American Society of Clinical Oncology Annual Meeting
Dr. Ray Page, Director of Research, was in Chicago at the American Society of Clinical Oncology Annual Meeting with over 30,000 oncology professionals around the world presenting their scientific advances. Dr. Page was the co-author of two scientific studies presented at the meeting. First of its kind data was shared on using Artificial Intelligence-based...
Read an article Dr. Page was a contributor to about Biosimilars in oncology practices.
Dr. Page says, "Our practice is one of the pioneer practices participating in the ASCOs PracticeNET program, sharing benchmark data across a variety of oncology practices. We participated in the data, but more importantly, represented it through the authorship of the publication." READ THE ARTICLE